MAP2K7 and neoplasm: Similarly, RAS signalling activates YAP, and there is evidence for involvement of YAP in tumour resistance to pharmacological RAF-MEK inhibition (Reddy & Irvine 2013, Lin et al. 2015, You et al. 2015).